Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up

Tainted batches of a short-term ulcer treatment, particulate contamination in a tested vial of a skin infection drug, and now, a shipment of heart health and hemophilia meds that may have switched packaging—Mylan marked its third recall of the year Friday, this time for four lots of two injectable drugs that may have been shipped in incorrectly-labeled cartons.

Mylan voluntarily recalled two lots each of its 450mg-per-9ml injectable amiodarone and 1,000 mg-per-10-ml injectable tranexamic acid over a potential packaging mix-up.